-
公开(公告)号:US20060040915A1
公开(公告)日:2006-02-23
申请号:US10513004
申请日:2002-04-26
申请人: Yatendra Kumar , Mohan Prasad , Ashok Prasad , Shailendra Singh , Neela Kumar
发明人: Yatendra Kumar , Mohan Prasad , Ashok Prasad , Shailendra Singh , Neela Kumar
IPC分类号: A61K31/545 , C07D501/14
CPC分类号: C07D501/22 , C07D501/00
摘要: The present invention relates to a process for the preparation of cefdinir on an industrial scale.
摘要翻译: 本发明涉及以工业规模制备头孢地尼的方法。
-
公开(公告)号:US20050080255A1
公开(公告)日:2005-04-14
申请号:US10498406
申请日:2002-12-12
申请人: Yatendra Kumar , Mohan Prasad , Ashok Prasad , Shailendra Singh , Neela Kumar
发明人: Yatendra Kumar , Mohan Prasad , Ashok Prasad , Shailendra Singh , Neela Kumar
IPC分类号: A61K31/546 , A61P31/04 , C07D501/00 , C07D501/22 , C07D501/14
CPC分类号: C07D501/00
摘要: The present invention relates to a novel crystalline cefdinir potassium dihydrate, to a process for its preparation and to a method of preparing pure cefdinir via the crystalline salt.
摘要翻译: 本发明涉及一种新的结晶头孢地尼钾二水合物,其制备方法和通过结晶盐制备纯头孢地尼的方法。
-
公开(公告)号:US20060094762A1
公开(公告)日:2006-05-04
申请号:US10541140
申请日:2004-01-07
申请人: Yatendra Kumar , Mohan Prasad , Neela Kumar
发明人: Yatendra Kumar , Mohan Prasad , Neela Kumar
IPC分类号: A61K31/44
CPC分类号: C07D401/12
摘要: Magnesium salts of rabeprazole, processes for preparing them, pharmaceutical compositions of the salts and their use in treatment or prevention of gastrointestinal ulcers are provided.
摘要翻译: 提供雷贝拉唑的镁盐,其制备方法,盐的药物组合物及其在治疗或预防胃肠溃疡中的用途。
-
公开(公告)号:US20060122233A1
公开(公告)日:2006-06-08
申请号:US10539681
申请日:2003-12-16
申请人: Yatendra Kumar , Mohan Prasad , Neela Kumar
发明人: Yatendra Kumar , Mohan Prasad , Neela Kumar
IPC分类号: A61K31/4439 , C07D403/02
CPC分类号: C07D401/12
摘要: The present invention relates to calcium salts of rabeprazole and processes for preparing rabeprazole calcium. The invention also relates to pharmaceutical compositions that include the rabeprazole calcium and use of said compositions for the treatment or prevention of gastrointestinal ulcers
摘要翻译: 本发明涉及雷贝拉唑的钙盐和雷贝拉唑钙的制备方法。 本发明还涉及包含雷贝拉唑钙的药物组合物和所述组合物用于治疗或预防胃肠溃疡的药物组合物
-
公开(公告)号:US20070060556A1
公开(公告)日:2007-03-15
申请号:US10555628
申请日:2004-05-03
申请人: Yatendra Kumar , Mahavir Khanna , Mohan Prasad
发明人: Yatendra Kumar , Mahavir Khanna , Mohan Prasad
IPC分类号: A61K31/555 , A61K31/4439 , C07D403/02
CPC分类号: C07D401/12 , A61K31/4439
摘要: A barium salt of the S-enantiomer of omeprazole which is (S)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole is provided. Further, processes for preparing the barium salt, pharmaceutical compositions comprising the salt and a method of treatment or prevention of gastrointestinal ulcers comprising administration of the salt are provided.
摘要翻译: 提供了(S)-5-甲氧基-2 - [[(4-甲氧基-3,5-二甲基-2-吡啶基) - 甲基]亚磺酰基] -1H-苯并咪唑的奥美拉唑的S-对映异构体的钡盐 。 此外,提供了制备钡盐的方法,包含该盐的药物组合物以及治疗或预防包括施用盐的胃肠溃疡的方法。
-
公开(公告)号:US20050054669A1
公开(公告)日:2005-03-10
申请号:US10909468
申请日:2004-08-02
申请人: Yatendra Kumar , Mohan Prasad , Asok Nath
发明人: Yatendra Kumar , Mohan Prasad , Asok Nath
IPC分类号: A61K31/4745 , C07D471/04
CPC分类号: C07D471/04
摘要: The present invention relates to processes for the preparation of zolpidem of Formula V as shown in the accompanying drawings or pharmaceutically acceptable salts thereof from N,N-dimethyl-3-(4-methyl)benzoyl propionamide of Formula II. The process includes (a) reacting N,N-dimethyl-3-(4-methyl)benzoyl propionamide of Formula II with bromine to get the bromo amide of Formula III; (b) condensing the bromo amide of Formula III with 2-amino-5-methylpyridine of Formula IV to get the zolpidem base of Formula V; and (c) converting zolpidem base of Formula V to its hemitartarate salt of Formula VII.
摘要翻译: 本发明涉及由式II的N,N-二甲基-3-(4-甲基)苯甲酰基丙酰胺制备式V的唑吡旦的方法或其药学上可接受的盐。 该方法包括(a)使式II的N,N-二甲基-3-(4-甲基)苯甲酰基丙酰胺与溴反应得到式III的溴酰胺; (b)将式III的溴酰胺与式IV的2-氨基-5-甲基吡啶缩合得到式V的唑吡旦基; 和(c)将式V的唑吡旦基转化为其式VII的半乳聚糖盐。
-
公开(公告)号:US08404854B2
公开(公告)日:2013-03-26
申请号:US12703004
申请日:2010-02-09
IPC分类号: C07D401/12
CPC分类号: C07D401/12 , A61K31/4439
摘要: The invention relates to crystalline barium salt of (S)-omeprazole, which is (S)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole. The invention also relates to processes for preparing crystalline barium salt of (S)-omeprazole and pharmaceutical compositions that include the crystalline barium salt of (S)-omeprazole so prepared.
-
公开(公告)号:US20110086884A1
公开(公告)日:2011-04-14
申请号:US12973499
申请日:2010-12-20
IPC分类号: A61K31/4439 , C07D401/12 , A61P1/04
CPC分类号: C07D401/12 , A61K31/4439
摘要: The invention relates to crystalline barium salt of (S)-omeprazole, which is (S)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole. The invention also relates to processes for preparing crystalline barium salt of (S)-omeprazole and pharmaceutical compositions that include the crystalline barium salt of (S)-omeprazole so prepared.
摘要翻译: 本发明涉及(S) - 奥美拉唑的结晶钡盐,其为(S)-5-甲氧基-2 - [[(4-甲氧基-3,5-二甲基-2-吡啶基) - 甲基]亚磺酰基〕-1H 苯并咪唑。 本发明还涉及制备(S) - 奥美拉唑的结晶钡盐的方法和包括如此制备的(S) - 奥美拉唑的结晶钡盐的药物组合物。
-
公开(公告)号:US07872140B2
公开(公告)日:2011-01-18
申请号:US12467051
申请日:2009-05-15
IPC分类号: C07D401/12
CPC分类号: C07D401/12 , A61K31/4439
摘要: The invention relates to crystalline barium salt of (S)-omeprazole, which is (S)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole. The invention also relates to processes for preparing crystalline barium salt of (S)-omeprazole and pharmaceutical compositions that include the crystalline barium salt of (S)-omeprazole so prepared.
摘要翻译: 本发明涉及(S) - 奥美拉唑的结晶钡盐,其为(S)-5-甲氧基-2 - [[(4-甲氧基-3,5-二甲基-2-吡啶基) - 甲基]亚磺酰基〕-1H 苯并咪唑。 本发明还涉及制备(S) - 奥美拉唑的结晶钡盐的方法和包括如此制备的(S) - 奥美拉唑的结晶钡盐的药物组合物。
-
公开(公告)号:US20100145058A1
公开(公告)日:2010-06-10
申请号:US12703016
申请日:2010-02-09
IPC分类号: C07D401/12
CPC分类号: C07D401/12 , A61K31/4439
摘要: The invention relates to crystalline barium salt of (S)-omeprazole, which is (S)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole. The invention also relates to processes for preparing crystalline barium salt of (S)-omeprazole and pharmaceutical compositions that include the crystalline barium salt of (S)-omeprazole so prepared.
摘要翻译: 本发明涉及(S) - 奥美拉唑的结晶钡盐,其为(S)-5-甲氧基-2 - [[(4-甲氧基-3,5-二甲基-2-吡啶基) - 甲基]亚磺酰基〕-1H 苯并咪唑。 本发明还涉及制备(S) - 奥美拉唑的结晶钡盐的方法和包括如此制备的(S) - 奥美拉唑的结晶钡盐的药物组合物。
-
-
-
-
-
-
-
-
-